PRESENTATIONS AT NATIONAL MEETINGS (1990-1997)
Presentations, 1990
Jan. 24-25
Indiana University, Indianapolis, IN
Prostatic Intraepithelial Neoplasia
March 3-7
USCAP Annual Meeting, Boston, MA
(see abstracts, 1990)
May 1-4
National Cancer Institute Roundtable on Prostate Cancer, Easton, MD
Premalignant Lesions of the Prostate
May 23
Osler Institute, Pathology Review Course, Hagerstown, MD
Gastrointestinal Pathology
June 29
University of Maryland Annual Meeting in Obstetrics and Gynecology, Anapolis,
MD Challenges in Gynecologic Pathology
July 10-11
National Cancer Institute Pathology Review and Workshop, Bethesda, MD
Prostatic Intraepithelial Neoplasia
July 23-25
American Assoc. of Clinical Chemistry Annual Meeting, San Francisco, CA
Pathology of Prostate Cancer
Presentations, 1991
Jan. 29
Central Ohio Society of Path., Columbus, OH
Prognostic Factors in Prostate Cancer
March 17-22
USCAP Annual Meetin,g Chicago, IL
(see abstracts, 1991)
April 13
Maryland Society of Urologists, Baltimore, MD
Pathology of Prostate Cancer
April 16
Detroit Society of Pathology, Detroit, MI
Selected Cases in Urologic Pathology
May 27
Osler Institute, Pathology Review Course, Columbus, OH
Gastrointestinal Pathology
Oct. 26-30
American Cancer Society, Sea Island, GA
Association of BPH and Prostate Cancer
Nov. 16
Illinois Society of Pathologists, Oak Brook, IL
Progress in Pathology of the Prostate
Presentations, 1992
Feb. 11-15
Amercian Cancer Society, Biannual Meeting San Francisco, CA
National Meeting on Prostate Cancer
May 2
American Cancer Society, Boston, MA
Early Diagnosis of Prostate Cancer
May 13-17 American
Urologic Association Annual Meeting, Washington, DC
Current Concepts of Prostate Disease
Sept. 26-27
Oklahoma State Path. Society, Tulsa, OK
Current
Concepts in Urologic Pathology
Oct. 15-18
National Cancer Institute Meeting, Prout's Neck, ME
Molecular Biology of Prostate Cancer
Dec. 2-5
California Tumor Tissue Registry Annual Meeting, San Francisco, CA
Current Concepts in Urologic Pathology
Presentations, 1993
Jan. 9-12
American Cancer Society, Atlanta, GA
Prostate Cancer Task Force
Jan. 15-17
American Joint Committee on Cancer, Scottsdale, AZ
Prognostic Factors in Prostate Cancer
Feb. 25-28
Mayo Medical Laboratories, Palm Springs, CA
Genitourinary Pathology
March 13-17
USCAP Annual Meeting, New Orleans, LA
Abstracts
April 24
American Urologic Association, Regional Meeting, Marco Island, FL
Prostate Cancer Pathology
May 16-20
American Urologic Association Annual Meeting, San Antonio, TX
Prostate Cancer Detection
May 24
Osler Institute, Pathology Review Course, Chicago, IL
Urologic Pathology
Sept. 14
Mayo Medical Laboratories, Rochester, MN
Practical Surgical Pathology
Sept. 23
Hawaii Society of Pathologists, Honolulu, HI
Precursors of Prostate Cancer
Oct. 16-19
ASCP Fall Meeting, Orlando, FL
Prostate Needle Biopsy Interpretation
Nov. 13
American Urologic Association Meeting on Prostate Cancer, Chicago, IL
Handling Radical Prostatectomy Specimens
Presentations, 1994
Jan. 28-30
Florida Society of Pathologists, Lake Buena Vista, FL
Prostate Cancer
Feb. 5-7
Utah Society of Pathologists, Park City, UT
Diagnostic Pathology of the Prostate
Feb. 9-13
National Cancer Institute, San Diego, CA
Chemoprevention of Prostate Cancer
April 8-9
Missouri Society of Pathologists, Kansas City, KS
Prostate Pathology
June 19-26
College of American Pathologists, Snowbird, UT
Prostate Cancer
Oct. 22-24
ASCP Fall National Meeting, Washington, DC
Prostate Needle Biopsy Interpretation
Nov. 12
Blue Ridge Pathology Society, Roanoke, VA
Prostate Pathology
Presentations, 1995
Jan. 20
Medical College of Pennsylvania, Philadelphia, PA
Precursors of Prostate: Current Concepts
Feb. 3-5
American Society of Clinical Pathologists, Las Vegas, NV
Prostatic Needle Biopsy Interpretation
Feb. 10
Mayo Medical Laboratories, Palm Springs, CA
Urinary Tract Pathology
Feb. 11-13
American Urologic Association, Dallas, TX
Urologic Pathology Review Course
March 23
Case Western Reserve Univ., Cleveland, OH
Origins of Prostatic Carcinoma
March 25
Southeastern Wisconsin Cancer Conference (American Cancer Society), Milwaukee,
WI
Prostate Cancer: Practical Aspects of Epidemiology and Pathology
April 22
American Society of Clinical Pathologists, Orlando, FL
Prostatic Needle Biopsy Interpretation
April 24-25
American Urologic Association, Las Vegas, NV
Prostate Cancer - Diagnosing It and Assessing Its Significance
May 8
Osler Institute - Pathology Review Course, Chicago, IL
Urological Pathology
June 7-8
Cambridge Healthtech Institute, Arlington, VA
Molecular Genetic Prognostic Factors in Prostate Cancer
Sept. 18-20
Fall ASCP National Meeting, New Orleans, LA
Prostate Pathology: Case Studies
Oct. 5-7
National Cancer Institute Conf, Easton, MD
PIN and Other Prostate Lesions as Risk Factors
Oct. 13
Eastern Cooperative Oncology Group, St. Louis, MO
PIN and Its Role in Chemoprevention Trial Strategy
Presentations, 1996
Jan. 15
SmithKline Beecham Urology Advisory Panel Meeting, Philadelphia, PA
PIN is a Precursor of Prostatic Cancer
Jan. 31
Twin Cities Society of Pathologists, Minneapolis, MN
PIN
Feb. 17-21
American Urologic Association, Dallas, TX
Urologic Pathology Review Course
Feb. 23-24
Oregon Pathologists Association, Portland, OR
Challenges of Prostatic Pathology
March 7-8
Incyte Pharmaceuticals, Palo Alto, CA
Mayo Medical Ventures
March 9-10
Pacific Northwest Cancer Foundation, Seattle, WA
March 23
Upper Midwest Chapter, American Urologic Association Allied, Rochester,
MN
PIN - Prostatic Intraepithelial Neoplasia
March 31- April 2
National Cancer Institute and Cygnus Corporation, Annapolis, MD
Prostate Cancer Prevention Workshop
April 12-13
UroCor, Inc. Oklahoma City, OK
April 20-25
American Society of Clinical Pathologists, Boston, MA
Boston Spring National Meeting
May 1
Academy of Medicine of New Jersey, Teterboro, NJ
PIN and Mimics of Adenocarcinoma
May 4-9
American Urologic Association, Orlando, FL
Poster - Optimized Microvessel Density Analysis
May 23-25
University of California School of Medicine, San Francisco, CA
New Developments in Prostate Cancer
New Developments in Bladder Cancer
July 1-2
American Cancer Society and National Cancer Institute, Washington, DC
Histologic Evolution of PIN
July 12
National Cancer Institute, Bethesda, MD
NCI Working Group for Research on Prognostic Factors and Systems
July 21-23
American Society of Clinical Pathologists, Chicago, IL
Prostatic Pathology: Update 1996
Aug. 6
American Cancer Society, Colorado Spring, CO
Detection &
Treatment Advisory Group on Prostate Cancer
Aug. 9-10
Medical Education Collaborative, Santa Barbara, CA
Pathology of Prostate Cancer
Aug. 24-25
College of American Pathologists, Santa Barbara, CA
Cancer Committee Meeting
Sept. 12-13
Mayo Medical Laboratories, Rochester, MN
Practical Surgical Pathology
Sept. 14
Amcerican Cancer Society, Orlando, FL
Florida Prostate Cancer Forum
Sept. 19
National Cancer Institute, Washington, DC
Pathology of Renal Carcinoma
Sept. 27-29
American Society of Clinical Pathologists, San Diego, CA
Challenges in Prostate Pathology
Oct. 11
University of Pittsburgh Cancer Institute, Pittsburgh, PA
Origins of Prostatic Carcinoma
Oct. 12-13
National Prostate Cancer Coalition, Houston, TX
Diagnosis and Prognosis Workshop Moderator
Oct. 27
Armed Forces Institute of Pathology, Washington, DC
Canine PIN and Prostate Cancer
Presentations, 1997
Jan 18
Atlanta, GA, American Cancer Society
Prostate Cancer Advistory Group Meeting
Jan 23-25
Beaver Creek, CO, Medical Education Collaboration
Origins of Prostate Cancer
Jan 31
Naples, FL, Schering-Plough Corp.
“Patients at Risk for Prostate Cancer”
Feb 8-9
Miami, FL, American Society of Clinical Pathology
“Prostate Biopsy Interpretation 1997”
Feb 14-17
Dallas, TX, American Urologic Association
Urologic Pathology
March 3-7
Orlando, FL, US and Canadian Academy of Pathology
Urologic Pathology
April 5
Chicago, IL, American Society of Clinical Pathology
“Prostate
Biopsy Interpretation 1997”
April 12-16
New Orleans, LA, American Urologic Association
“Prognostic Factors in Prostate Cancer”
May 10
Ann Arbor, MI, Michigan Society of Pathology
“Diagnosis of Premalignant Lesions and Small Foci of Cancer in the
Prostate”
May 16
Boston, MA, Harvard Medical School
“Urologic Pathology”
June 20
Santa Rosa, CA, American Cancer Society of Kaiser, CA
“Evaluating Prostate Needle Biopsy: Therapuetic and Prognostic Importance”
Grand Rounds
June 21
Ukiah, CA, American Cancer Society
“What a Patient Should Know About Prostate Cancer”
June 21-22
Sonoma, CA, Sonoma Conference on Prostate Cancer
Angiogenesis in Prostate Cancer
July 3-7
Chantilly, VA, National Cancer Institute
Prostate Cancer Progress Review
July 16
Aspen, CO, Aspen Conference on Carcinogenesis
“Update on Prostate Cancer Origins”
July 23
New York, NY, American Cancer Society
Meeting of Editorial Board of CANCER
Aug 3-5
San Diego, CA, Hybritech - Mayo Collaboration
“Immunohisto-chemical Studies of human glandular Kallikrein 2”
Aug 2-8
San Diego, CA, US and Canadian Academy of Pathology
‘Diagnostic Pathology 1997”
Aug 15-16
Purdue, IN, Purdue University and World Health Organization
“Animal Models of Prostate Cancer”
Sept 4-5
Seattle, WA, University of Washington NW
Prostate Cancer Conference
Sept 20
Philadelphia, PA, American Society of Clinical Pathology
“Prostate Biopsy Interpretation 1997”
Sept 27-28
Boston, MA, (Research)
Canine Studies
Oct 7
Chicago, IL, Abbott Laboratories
Immunohisto-chemical findings
Nov 6-9
Charlotte, NC, Southern Medical Association Annual Meeting
Prostate Biopsy Interpretation
Dec 12
Orlando, FL, Armed Forces Institute of Pathology
“Prostate Biopsy Interpretation” and “Handling Radical
Prostatetomies.”
Back to Dr. Bostwick's Educational & Professional Background